Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |